VEGFR3通过β-抑制蛋白1调控内皮功能
该研究结合人类PAH样本、人肺微血管内皮细胞和Arrb敲除小鼠,探究ARRB1在内皮VEGFR3信号中的作用。结果显示,人类PAH中ARRB1与VEGFR3表达降低,缺氧小鼠敲除Arrb1后PAH加重且VEGFR3信号丢失,敲低ARRB1抑制VEGF-C诱导的内皮细胞增殖、迁移和成管。ARRB1直接结合VEGFR3激酶结构域并减少其内化,提示ARRB1是VEGFR调控的新节点及GPCR与VEGFR间交叉对话机制。
要点
- 人类PAH中ARRB1与VEGFR3表达降低,提示二者参与PAH发病。
- 缺氧小鼠敲除Arrb1导致PAH加重并丢失VEGFR3信号。
- ARRB1直接结合VEGFR3激酶结构域,减少VEGFR3内化。
核心结论
- ARRB1通过直接结合VEGFR3激酶结构域并减少其内化,正向调控内皮VEGFR3信号。
- 促进ARRB1介导的VEGFR3信号可能成为肺动脉高压及其他血管疾病的治疗策略。
研究设计与样本
- 研究使用人类PAH样本、人肺微血管内皮细胞和Arrb敲除小鼠,结合生化分析探究ARRB1在内皮VEGFR3信号中的作用。
主要发现
- 人类PAH中ARRB1与VEGFR3表达降低。
- 缺氧小鼠敲除Arrb1后PAH加重,并出现VEGFR3信号丢失。
- 敲低ARRB1抑制VEGF-C诱导的内皮细胞增殖、迁移和成管,并降低VEGFR3、Akt和内皮型一氧化氮合酶磷酸化。
- ARRB1直接结合VEGFR3激酶结构域,导致VEGFR3内化减少。
临床怎么用
- ARRB1-VEGFR3轴可作为肺动脉高压等血管疾病的潜在干预靶点,但尚需临床转化验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Receptor signaling is central to vascular endothelial function and is dysregulated in vascular diseases such as atherosclerosis and pulmonary arterial hypertension (PAH). Signaling pathways involved in endothelial function include vascular endothelial growth factor receptors (VEGFRs) and G protein-coupled receptors, which classically activate distinct intracellular signaling pathways and responses. The mechanisms that regulate these signaling pathways have not been fully elucidated and it is unclear what nodes for cross talk exist between these diverse signaling pathways. For example, multifunctional β-arrestin (ARRB) adapter proteins are best known as regulators of G protein-coupled receptor signaling, but their role at other receptors and their physiological importance in the setting of vascular disease are unclear. METHODS: We used a combination of human samples from PAH, human microvascular endothelial cells from lung, and Arrb knockout mice to determine the role of ARRB1 in endothelial VEGFR3 signaling. In addition, a number of biochemical analyses were performed to determine the interaction between ARRB1 and VEGFR3, signaling mediators downstream of VEGFR3, and the internalization of VEGFR3. RESULTS: Expression of ARRB1 and VEGFR3 was reduced in human PAH, and the deletion of Arrb1 in mice exposed to hypoxia led to worse PAH with a loss of VEGFR3 signaling. Knockdown of ARRB1 inhibited VEGF-C-induced endothelial cell proliferation, migration, and tube formation, along with reduced VEGFR3, Akt, and endothelial nitric oxide synthase phosphorylation. This regulation was mediated by direct ARRB1 binding to the VEGFR3 kinase domain and resulted in decreased VEGFR3 internalization. CONCLUSIONS: Our results demonstrate a novel role for ARRB1 in VEGFR regulation and suggest a mechanism for cross talk between G protein-coupled receptors and VEGFRs in PAH. These findings also suggest that strategies to promote ARRB1-mediated VEGFR3 signaling could be useful in the treatment of pulmonary hypertension and other vascular disease.
引用
- Ma Z, Yu YR, Badea CT, et al. Vascular Endothelial Growth Factor Receptor 3 Regulates Endothelial Function Through β-Arrestin 1. Circulation. 2019. PMID: 30586762. doi:10.1161/CIRCULATIONAHA.118.034961
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。